Skip to main content

Cellomics to Provide HCS Equipment for China s National Center for Drug Screening

NEW YORK, Sep 2 (GenomeWeb News) - Cellomics said today that it is collaborating with the National Center for Drug Screening in Shanghai, China, in the area of high content screening.


Cellomics will serve as a "strategic partner" in the establishment of an HCS program at the center, according to a statement by Ming-Wei Wang, director of the NCDS. Further terms of the agreement were not provided.


The NationalCenter for Drug Screening is affiliated with the Shanghai Institute of Materia Medica at the ChineseAcademy of Sciences.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.